<DOC>
	<DOCNO>NCT02146209</DOCNO>
	<brief_summary>The purpose study determine whether Terix Labs Ltd Metronidazole benzoate ( 400 mg Metronidazole Per Sachet Oral Granules ) bioequivalent 500 mg Sanofi-aventis Flagyl 125 mg/5 ml ( 125 mg Metronidazole Per 5 ml Suspension ) Zentiva Flagyl™ 400 mg Tablets ( 400 mg Metronidazole Per Film Coated Tablets ) .</brief_summary>
	<brief_title>Study Determine Equivalence Three Products Containing Metronidazole Benzoate .</brief_title>
	<detailed_description>This study pilot study exploit exploratory purpose compare absorption disposition kinetics three product contain metronidazole fasting condition . These product : Metronidazole benzoate ( formula A ) , Test product manufacture ONE PHARMA , Greece . Flagyl 125 mg/5 ml ( formula B ) , Reference product manufacture Unither Liquid Manufacturing , France Flagyl™ 400 mg Tablets ( formula C ) , Reference product manufacture Famar Health Care Services , Spain . The bioequivalence single 400 mg dose product A C , single 500 mg dose product B assess compare pharmacokinetic parameter derive plasma concentration-time profile metronidazole .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Age 18 50 year , inclusive . Body Mass Index ( BMI ) range within 18.5 30 Kg/m2 . Subject known allergy drug investigation ingredient related drug . Medical demographic perform longer two week initiation clinical study significant deviation normal range . Results laboratory test within normal range except Hb RBC indices test within 5 % reference range kidney function test ( Creatinine accept reference range ) outside reference range . ( Laboratory test perform longer two week initiation clinical study ) . Acute infection within one week precede first study drug administration . History drug alcohol abuse . Subject heavy smoker ( 10 cigarette per day ) . Subject agree take prescription nonprescription drug within two week precede first study drug administration donate last sample study . Subject agree take vitamin take nutritional purpose within two day first study drug administration donate last sample study . Subject special diet ( example subject vegetarian ) . Subject consumes large quantity alcohol beverage contain methylxanthines e.g . caffeine ( coffee , tea , cola , chocolate etc ) . Subject agree consume beverage food contain alcohol 48 hour prior study drug administration donate last sample respective period . Subject agree consume beverage food contain methylxanthines e.g . caffeine ( coffee , tea , cola , chocolate etc . ) 24 hour prior study drug administration end confinement period . Subject agree consume beverage food contain grapefruit 7 day prior first study drug administration donate last sample study . Subject history severe disease direct impact study . Participation bioequivalence study clinical study within last 80 day first study drug administration . Subject intend hospitalize within 3 month first study drug administration . Subjects donate blood derivative past 3 month completion study , would donate 1250 ml 120 day , 1500 ml 180 day , 2000 ml 270 day , 2500 ml blood 1 year . Subject history significant asthma , peptic gastric ulcer , sinusitis , pharyngitis , renal disorder ( impaired renal function ) , hepatic disorder ( impaired hepatic function ) , cardiovascular disorder , neurological disease epilepsy , haematological disorder diabetes , psychiatric , dermatologic immunological disorder . Subject engage strenuous exercise least one day prior dose till last sample respective period . Subject screen examination pulse outside normal range ( 60100 beat per minute ) body temperature outside normal range ( 36.437.7 ○C ) respiratory rate outside normal range ( 1420 breath per minute ) sit blood pressure le 100/60 mm Hg equal 140/90 mm Hg . Subject history difficulty swallow gastrointestinal disease could affect drug absorption .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>